| Market Cap | 16.61M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -7.47M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | -18.00% |
| Sales | 25.54k | PEG | - | EPS past 5Y | - | 200D Avg Chg | -37.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -89.00% |
| Recommedations | - | Quick Ratio | 0.00 | Shares Outstanding | 632.47M | 52W Low Chg | 43.00% |
| Insider Own | 61.21% | ROA | -1,130.07% | Shares Float | 243.49M | Beta | 0.26 |
| Inst Own | - | ROE | - | Shares Shorted/Prior | -/- | Price | 0.03 |
| Gross Margin | 13.47% | Profit Margin | - | Avg. Volume | 31,948 | Target Price | - |
| Oper. Margin | -94,758.98% | Earnings Date | - | Volume | 24,090 | Change | -16.39% |
ALR Technologies SG Ltd., a data management company, provides diabetes care management solutions for human and animal health diabetes. It offers ALRT Diabetes Solution, a diabetes care that includes a diabetes management system that collects data directly from blood glucose meters and continuous glucose monitoring devices, and Predictive A1C algorithm to track treatment success between lab reports and an FDA-cleared Insulin Dosing Adjustment program. The company also provides GluCurve Pet CGM, a solution to assist veterinarians determine the efficacy of insulin treatments and to help to identify the appropriate dose and frequency of administration for companion animals. The company sells its products directly and through distributors in the United States, Brazil, the United Kingdom, European Union, and internationally. The company was incorporated in 1987 and is based in Singapore.
